Drug Shortage Report for HYDROMORPHONE HYDROCHLORIDE INJECTION USP
| Report ID | 147161 |
| Drug Identification Number | 02485540 |
| Brand name | HYDROMORPHONE HYDROCHLORIDE INJECTION USP |
| Common or Proper name | Hydromorphone Hydrochloride Injection USP |
| Company Name | STERINOVA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
| Strength(s) | 40MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 30 x 100 mL |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2021-10-15 |
| Actual start date | 2021-10-15 |
| Estimated end date | 2021-11-05 |
| Actual end date | 2021-11-04 |
| Shortage status | Resolved |
| Updated date | 2021-11-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3005 AVENUE JOSE-MARIA ROSELL SAINT-HYACINTHE, QUEBEC CANADA J2S 0J9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2021-10-14 | English | Compare |
| v2 | 2021-10-14 | French | Compare |
| v3 | 2021-10-14 | French | Compare |
| v4 | 2021-10-16 | English | Compare |
| v5 | 2021-11-04 | English | Compare |
| v6 | 2021-11-04 | French | Compare |
| v7 | 2021-11-05 | English | Compare |
Showing 1 to 7 of 7